Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Aeilko H Zwinderman

Showing results (421-430 of 480) with videos related to

Pageof 48
Sort By:
JAMA|March 29, 2012
Association of LDL cholesterol, non-HDL cholesterol, and apolipoprotein B levels with risk of cardiovascular events among patients treated with statins: a meta-analysisS Matthijs Boekholdt, Benoit J Arsenault, Samia Mora, et al.
Journal of Neuro-Oncology|June 26, 2019
Between-hospital variation in mortality and survival after glioblastoma surgery in the Dutch Quality Registry for Neuro SurgeryPhilip C De Witt Hamer, Vincent K Y Ho, Aeilko H Zwinderman, et al.
Expert Opinion on Therapeutic Targets|January 26, 2010
Vitamin D receptor: a new risk marker for clinical restenosis after percutaneous coronary interventionPascalle S Monraats, Yue Fang, Douwe Pons, et al.
Cardiovascular Research|January 30, 2024
Networks of gut bacteria relate to cardiovascular disease in a multi-ethnic population: the HELIUS studyMoritz V Warmbrunn, Ulrika Boulund, Judith Aron-Wisnewsky, et al.
Pharmacogenetics and Genomics|September 27, 2006
Inflammation and apoptosis genes and the risk of restenosis after percutaneous coronary interventionPascalle S Monraats, Florentine de Vries, Laura W de Jong, et al.
Annals of Neurology|March 14, 2002
Comparison of weakness progression in inclusion body myositis during treatment with methotrexate or placeboUmesh A Badrising, Marion L C Maat-Schieman, Michel D Ferrari, et al.
International Journal of Cardiology|January 8, 2018
Fibroblast growth factor 23 is related to profiles indicating volume overload, poor therapy optimization and prognosis in patients with new-onset and worsening heart failureJozine M Ter Maaten, Adriaan A Voors, Kevin Damman, et al.
International Journal of Cardiology|October 18, 2012
Lamin A/C mutation is independently associated with an increased risk of arterial and venous thromboembolic complicationsIngrid A W van Rijsingen, Annemieke Bakker, Donija Azim, et al.
Clinical Proteomics|November 10, 2018
Using matrix assisted laser desorption ionisation mass spectrometry (MALDI-MS) profiling in order to predict clinical outcomes of patients with heart failureThong Huy Cao, Donald J L Jones, Paulene A Quinn, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|July 19, 2019
Glycoproteomic Analysis of the Aortic Extracellular Matrix in Marfan PatientsXiaoke Yin 殷晓科, Shaynah Wanga, Adam L Fellows, et al.
Pageof 48

Showing results (421-430 of 480) with videos related to

Sort By:
Pageof 48
JAMA|March 29, 2012
Association of LDL cholesterol, non-HDL cholesterol, and apolipoprotein B levels with risk of cardiovascular events among patients treated with statins: a meta-analysisS Matthijs Boekholdt, Benoit J Arsenault, Samia Mora, et al.
Journal of Neuro-Oncology|June 26, 2019
Between-hospital variation in mortality and survival after glioblastoma surgery in the Dutch Quality Registry for Neuro SurgeryPhilip C De Witt Hamer, Vincent K Y Ho, Aeilko H Zwinderman, et al.
Expert Opinion on Therapeutic Targets|January 26, 2010
Vitamin D receptor: a new risk marker for clinical restenosis after percutaneous coronary interventionPascalle S Monraats, Yue Fang, Douwe Pons, et al.
Cardiovascular Research|January 30, 2024
Networks of gut bacteria relate to cardiovascular disease in a multi-ethnic population: the HELIUS studyMoritz V Warmbrunn, Ulrika Boulund, Judith Aron-Wisnewsky, et al.
Pharmacogenetics and Genomics|September 27, 2006
Inflammation and apoptosis genes and the risk of restenosis after percutaneous coronary interventionPascalle S Monraats, Florentine de Vries, Laura W de Jong, et al.
Annals of Neurology|March 14, 2002
Comparison of weakness progression in inclusion body myositis during treatment with methotrexate or placeboUmesh A Badrising, Marion L C Maat-Schieman, Michel D Ferrari, et al.
International Journal of Cardiology|January 8, 2018
Fibroblast growth factor 23 is related to profiles indicating volume overload, poor therapy optimization and prognosis in patients with new-onset and worsening heart failureJozine M Ter Maaten, Adriaan A Voors, Kevin Damman, et al.
International Journal of Cardiology|October 18, 2012
Lamin A/C mutation is independently associated with an increased risk of arterial and venous thromboembolic complicationsIngrid A W van Rijsingen, Annemieke Bakker, Donija Azim, et al.
Clinical Proteomics|November 10, 2018
Using matrix assisted laser desorption ionisation mass spectrometry (MALDI-MS) profiling in order to predict clinical outcomes of patients with heart failureThong Huy Cao, Donald J L Jones, Paulene A Quinn, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|July 19, 2019
Glycoproteomic Analysis of the Aortic Extracellular Matrix in Marfan PatientsXiaoke Yin 殷晓科, Shaynah Wanga, Adam L Fellows, et al.
Pageof 48